Asan Medical Center
Clinical trials sponsored by Asan Medical Center, explained in plain language.
-
Can surgery buy more time for women with returning ovarian cancer?
Disease control Not yet recruitingThis study looks at whether adding surgery after chemotherapy can help women with platinum-sensitive recurrent ovarian cancer live longer without their cancer growing. About 160 participants whose tumors shrank with chemo will be randomly assigned to get surgery plus more chemo o…
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 17, 2026 08:25 UTC
-
Blood thinner showdown: aspirin vs warfarin after valve surgery
Disease control Not yet recruitingThis study compares two blood-thinning medicines, aspirin and warfarin, to see which is safer for preventing clots in the first 6 months after a tissue heart valve replacement. About 1,058 adults who had aortic or mitral valve surgery will be randomly assigned to one of the two t…
Phase: PHASE4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
Can a simple gas help fragile newborns breathe easier?
Disease control Not yet recruitingThis study tests whether inhaled nitric oxide can help newborns with a hole in their diaphragm (congenital diaphragmatic hernia) who also have high blood pressure in their lungs. About 40 babies will receive the gas, and doctors will check if their oxygen levels improve. The goal…
Phase: PHASE4 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Blood test may decide who needs more chemo after esophageal cancer surgery
Disease control Not yet recruitingThis study tests whether a blood test that detects tiny bits of tumor DNA can help decide who should get extra chemotherapy after esophageal cancer surgery. About 172 adults with stage 2 or 3 esophageal cancer will be randomly assigned to either receive chemotherapy plus an immun…
Phase: PHASE3 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New hope for liver cancer patients: drug combo after immunotherapy fails
Disease control Not yet recruitingThis study tests two oral drugs, lenvatinib and regorafenib, in people with advanced liver cancer that worsened after initial immunotherapy. The goal is to see how well these drugs control tumor growth and extend life. About 146 adults with varying liver function will take the me…
Phase: PHASE2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated May 07, 2026 18:42 UTC
-
Blood thickness during brain surgery linked to complications?
Knowledge-focused Not yet recruitingThis study will observe 1000 adults having planned brain surgery to see if the thickness of their blood during the operation is linked to problems like infections, kidney injury, or death within 30 days. Researchers will measure blood viscosity and oxygen levels in the brain. The…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
Blood test could spot cancer return months before scans
Knowledge-focused Not yet recruitingThis study will test a new blood test that looks for tiny bits of cancer DNA (called MRD) in 600 people with endometrial or cervical cancer. The goal is to see if this test can find cancer coming back earlier than current methods like CT scans. Participants will give blood sample…
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:01 UTC
-
New ultrasound study aims to reduce risks during common vein procedure
Knowledge-focused Not yet recruitingThis study uses ultrasound to compare two ways of looking at a large vein under the collarbone (the subclavian vein) to see which is safer for inserting catheters. Researchers will scan 55 adults during anesthesia, measuring how far the vein is from the lung and artery. The goal …
Sponsor: Asan Medical Center • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC